Curcumin: Getting Back to the Roots
By S. Shishodia, Gautam Sethi, Bharat B. Aggarwal. Annals of the New York Academy of Sciences, 2005
737 citations recorded by the source corpus.
Subfields: Complementary and alternative medicine, Molecular Medicine, Pharmacology
View Paper: https://www.semanticscholar.org/paper/eb5b16d4072a0c4004b7bbdd9d9132c64f3b6697
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Medicine
In Pharmacology
Citations in the corpus
- Novel insights of dietary polyphenols and obesity. (2014, neutral): “Curcumin comprises 2%–8% of turmeric [129].”
- Molecular targets of dietary agents for prevention and therapy of cancer. (2006, background): “Curcumin as well as various other curcuminoids from ginger family mediate their therapeutic effects by regulating the transcription factor NF-kB and NF-kB regulated gene products COX-2, cyclin D1, adhesion molecules, MMPs, inducible nitric oxide synthase, Bcl-2, Bcl-XL and TNF [31].”
- Targets of curcumin (2011, background): “Over the last 60 years, more than 3000 studies have demonstrated curcumin has antioxidant, antibacterial, antifungal, antiviral, anti-inflammatory, antiproliferative, proapoptotic and anti-atherosclerotic effects, exerting medicinal benefits against neurodegenerative diseases, arthritis, allergy, in”
- Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy (2007, background): “Page 1 of 18 (page number not for citation purposes) Background Curcumin or diferuloylmethane is a yellow polyphenol extracted from the rhizome of turmeric (Curcuma longa), a plant grown in tropical Southeast Asia [1].”
- Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. (2008, neutral): “[5] Shishodia S, Sethi G, Aggarwal BB.”